Neuroscience News

New research by Institute affiliate Leanne Williams adds to the evidence that choosing treatment based on the neurological underpinnings of a patient’s depre

This week on From Our Neurons to Yours, we talk with Leanne Williams about distinctive biotypes of depression revealed by brain imaging and AI, and the implications for therapy and mental health.

Research by Kati Andreasson and colleagues suggests that a type of drug developed for treating cancer may hold promise as a new treatment for neurodegenerati

A team of neuroscientists at the Knight Initiative for Brain Resilience have zeroed in on a critical regulator of brain metabolism that may be over-activated in the brains of patients with Alzheimer’s disease.

It may feel like you’re being more productive, but experts like Anthony Wagner say you’re not.

Time marches on predictably, but biological aging is anything but constant, according to new research by Michael Snyder and colleagues.

This week on From Our Neurons to Yours, we talk with Michelle Monje about her discovery that many cancers depend on nervous system innervation; she also discusses opportunities for novel therapies.

This week on From Our Neurons to Yours, we talk with Sergiu Pasca about using new techniques for growing human brain tissue in the lab to solve a rare neurological disorder.

This week, we talk with "radical behaviorist" Kim Bullock about how virtual reality technologies could serve as behavioral therapeutics to enhance psychotherapy.

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease, but which also carry safety risks according to Knight Initiative for Brain Resilience affiliate Mike Greicius and others.

Experts at Stanford Medicine Children’s Health helped conduct clinical trials for the new therapy, which gives kids with X-linked adrenoleukodystrophy, or ALD, a functioning copy of the abnormal gene.

This week, we talk with Michelle Monje and Rob Malenka about recent findings on the role of myelin plasticity in opioid addiction.

In an analysis of more than 2 million patient records, researchers discovered that people taking angiotensin receptor blockers for high blood pressure were less likely to develop epilepsy.

Brain imaging, known as functional MRI, combined with machine learning can predict a treatment response based on one’s depression “biotype.”

To advance neuroscience research using EEG and TMS technologies, the Koret Human Neurosciences Community Lab has awarded its inaugural Human Neuroscience Pilot Grants to ten innovative research projects.

Wu Tsai Neuro affiliate Michelle Monje and team discovered that adaptive myelination, a form of brain plasticity, contributes to drug addiction. A single morphine dose in mice triggered myelination in reward-related brain circuits, reinforcing drug-seeking behavior. Blocking this myelination prevented addiction, highlighting potential new treatment strategies.